Skip to content
healthcare.dev

BRIXADI

NDC 58284-228, BUPRENORPHINE, injection, from Braeburn Inc..

Product NDC
58284-228
Status
Listed
Labeler
Braeburn Inc.
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA210136
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58284-228 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPRENORPHINE128 mg/.36mL

Pharmacologic classes

Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]

Package NDCNDC-11Package
58284-228-01582840228011 SYRINGE, GLASS in 1 CARTON (58284-228-01) / .36 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5d8a8fd0-8619-422a-a664-d1d2e8970f48
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=58284-228

Use it

Look up 58284-228 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58284-228 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58284-228. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.